Completed NA INTERVENTIONAL 2-arm NCT00534690

Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation? (REVOLU)

Lowering VT and Increasing PEP During One-Lung Ventilation (OLV), Impact on Oxygenation

Sponsor: University Hospital, Bordeaux

Conditions Lung Neoplasms Pulmonary Disease

Interventions One-Llung ventilation One-Lung ventilation

Updated 5 times since 2017 Last updated: Jan 20, 2010 Started: Nov 30, 2007 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lung Neoplasms and Pulmonary Disease and is currently completed. University Hospital, Bordeaux leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pessac, France